Salming, 71 announced he had ALS last month and it shook up Sweden and the hockey world. He is a highly respected and extremely popular Hall of Fame player. He played almost all of his career with the Toronto Maple Leafs, but he ended his NHL career wearing a Detroit Red Wings uniform. Salming played his final NHL game for Detroit against the Philadelphia Flyers on April 1, 1990.
The Food and Drug Administration advisers voted 7-2 that data from Amylyx Pharma warranted approval, despite ongoing concerns about the strength and reliability of the company’s study. The vote is not binding and the FDA will make its final decision by the end of the month.
Together, these findings add evidence to the hypothesis that a reactivation of the HERV-K virus plays a role in the development of ALS, and that an antibody response against it is protective. These data also suggest the possibility that treatment with a synthetic antibody raised against HERV-K-ENV might have beneficial effects in those persons with ALS who also have evidence of HERV-K reactivation.
There is no cure for ALS, which Linda Lindy Anne Lund was diagnosed with last year
"My sweet mother Lindy has lost her battle with ALS," Vonn wrote in an Instagram post. "She passed away peacefully as I held her hand, exactly one year after her diagnosis. I am so grateful for every moment I had with her but I am also thankful that she is no longer suffering and in peace. She was a shining light that will never fade and I will forever be inspired by her."
"It makes me incredibly proud of Rhode Island because I think people underestimate us a lot. We're the smallest state, but I think what we've proved again a second year in a row is that we might be the smallest but we have the biggest heart and when Rhode Islanders get together to join a cause they really show up for it," said Beth Flanagan, executive director of the ALS Rhode Island Chapter.
With philanthropic support from Never Surrender Inc., Essentia Health will become one of about 50 sites participating in the HEALEY ALS Platform Trial, an initiative led by the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital (MGH) and the Northeast ALS Consortium (NEALS). This groundbreaking perpetual study opened for enrollment in July 2020 and aims to accelerate the development of effective treatments for ALS, or amyotrophic lateral sclerosis.
This year marks the 20th of up to $5,000 in Joseph W. Mayo ALS Scholarships being awarded to Maine men and woman attending traditional and nontraditional educational programs in memory of Mayo, a former state representative from Thomaston.